Background: Neonatal jaundice (NNJ) or hyperbilirubinemia is a ubiquitous condition in newborn infants. Currently, the transcutaneous bilirubinometer is used to screen for NNJ in health care facilities, where neonates need to be physically present (ie, a centralized model of care for NNJ screening). Mobile health (mHealth) apps present a low-cost, home-based, and noninvasive system that could facilitate self-monitoring of NNJ and could allow mothers the convenience of screening for NNJ remotely. However, end users’ acceptability of such mHealth apps is of fundamental importance before the incorporation of such apps into clinical practice. Objective: The study aimed to explore the perception of postpartum mothers toward self-monitoring of NNJ using a novel mHealth app. Methods: Mothers attending video consultations for early postpartum care at 2 Singapore primary care clinics watched an instructional video for a hyperbilirubinemia-screening mHealth app (HSMA). An independent researcher used a semistructured topic guide to conduct in-depth interviews with 25 mothers, assessing their views on HSMAs. All interviews were audio recorded, transcribed verbatim, and checked for accuracy before data analysis. Two researchers independently analyzed the transcripts via thematic analysis. Data were managed using NVivo qualitative data management software. Results: The identified themes were grouped under perceived usability and utility. Mothers valued the convenience and utility of HSMAs for remote monitoring of NNJ. They appreciated the objectivity the app readings provided compared to visual inspection. However, they perceived that the app’s applicability would be restricted to severe jaundice, were concerned about its accuracy and restriction to the English language, and lacked confidence in using it. Nevertheless, they were willing to use it once its accuracy was proven and when they received adequate guidance from health care professionals. They also suggested including an action plan for the measured readings and clinical signs within the app. Mothers proposed pairing teleconsultations with HSMAs to boost their confidence and enhance adoption. Conclusions: Mothers were receptive to using HSMAs but had concerns. Multiple languages, proof of accuracy, and resources to guide users should be incorporated into the app in the next phase to increase its successful adoption. Complementing such apps with a teleconsultation service presents a plausible and pragmatic NNJ care delivery model in general practice.
1 January 2026 in Journal of Primary Care & Community Health
Background: Global Initiative for Asthma (GINA) has recommended inhaled corticosteroid (ICS)-Formoterol as Track-1 treatment for patients. Using ICS and SABA (Short-Acting Beta-Agonist) as a reliever is an alternative Track-2 option. Both modalities are tied to type of inhaler use, dry powder inhalers (DPI) and propellent-containing metered-dose inhalers (pMDI). Compared to propellent-free DPI, pMDI have much higher carbon footprint (CF) detrimental to the environment. Leveraging on dispensed inhaler data from the electronic medical records of patients managed in primary care, the study aimed to quantify their CF using Budesonide-Formoterol (BUD-FOR) DPI alone, compared to those who were treated with BUD-FOR DPI + pMDI as a reliever. Methods: Electronic medical records from 8 public primary care clinics were analysed, covering adult asthma patients (aged ≥21) between 2018 and 2023. Data on inhaler dispensing, asthma control test (ACT) scores and rescue therapy (RT) needs were assessed. CF was computed based on inhaler canisters dispensed. Associations between treatment modality, asthma control, RT and CF were analysed using Generalized Estimating Equations. Results: A total of 5634 patients using BUD-FOR DPI were included. Over the study period, Track-1 usage increased substantially from 466 to 2317 patients, while Track-2 rose modestly from 628 to 758. In 2023, 78.5% of patients achieved good asthma control compared to 68.7% in Track-2. The total CF per patient was substantially lower in Track-1 compared to Track-2 (3.3 vs 62.4 kgCO₂e). Patients in Track-1 had a significantly lower CF by 60 kgCO₂e ( P < .001), had 1.5 times higher odds to achieve good asthma control based on ACT scores ( P < .001) and had approximately 30% lower odds of receiving RT ( P < .001). The average number of SABA-pMDI canisters dispensed per patient declined from 2.8 to 2.1 over the study period. BUD/FOR inhalers use per patient per year was consistently higher in Track 2 compared to Track 1, with an average difference of 1.2 canisters (5.3 vs 4.1). Conclusion: Patients managed under Track-1 treatment approach demonstrated significantly better asthma outcomes and lower CF. These findings highlight potential of Track-1 treatment as the preferred strategy, enabling better clinical outcomes and reduced environmental impact.
1 January 2024 in Proceedings of Singapore Healthcare
Background: HbA1c test is the most-ordered laboratory test in public primary care clinics, accounting for 17% of laboratory services. In recent years, there has been growing adoption of self-service technology in taking clinical measurements. However, there are currently no on-site self-testing HbA1c facilities. This study assessed patients’ acceptability and ability to perform self-testing of HbA1c levels and the feasibility of implementation in primary care setting. Methods: A total of 30 eligible diabetic patients were recruited in Tampines Polyclinic. Participants were shown a demonstration video before self-testing with a Point-of-Care HbA1c analyzer and completed a questionnaire after self-testing. The usability of the system was assessed using System Usability Scale (SUS). Acceptance and ability were assessed using either a five or six point-Likert Scale for the 7-step procedure. Fisher’s exact test was used to test for association with SUS score. Results: The study population comprises mainly males (60.0%), Chinese (50.0%), had highest qualification of secondary education and beyond (80.0%), with a mean age of 61.4 ± 8.3 years. The mean SUS score was 66.5 ± 13.3 and the average time taken to complete the HbA1c self-testing was 11.8 ± 4.5 min. No significant association was observed between demographics and SUS score. Although 40.0% of participants experienced some difficulty in inserting the cartridge into the analyzer, all were able to understand and follow the video and were willing to perform self-testing in the future. Conclusion: There is high level of acceptance and ability among diabetic patients to adopt HbA1c self-testing. It is feasible for use in primary care.
Background: Global reports on hypertension phenotypes exist, but population‑based evidence remains limited. A significant gap also persists in understanding these phenotypes within multi‑ethnic urban populations. Thus, this study aimed to determine the prevalence of hypertension phenotypes and their associated factors in a low-risk population in Singapore. Methods: The cross-sectional study analysed data from 981 adults aged 21–69 years with a low 10-year cardiovascular risk (based on the 2023 Singapore modified Framingham risk score) and not on any antihypertensives. Participants were recruited from public or clinic settings using convenience sampling. Following consent, participants completed clinical examinations and investigations using structured questionnaires and validated instruments, such as office BP and 24-hour ambulatory BP monitoring (ABPM) devices. Results: The mean age of the participants was 45.5 years (SD 11.8 years). Most were females (51.6%) and of Chinese ethnicity (91.2%). Normal body mass index (BMI) and waist circumference were observed in 47.0% and 60.7% of the cohort, respectively. Lifestyle data revealed that most participants were nonsmokers (90.9%) and engaged in physical activity (81.3%). The prevalence of hypertension was 25.5% by office BP and 22.7% by 24-hour ABPM, with 38.5% diagnosed via any ABPM target. Nocturnal hypertension (NH) was the most prevalent hypertension phenotype (36.1%), while white-coat hypertension had the lowest prevalence (6.5%). Daytime hypertension and masked hypertension (MH) were observed in 17.4% and 19.4% of participants, respectively. A non-dipping (ND) BP pattern was identified in 59.7% of the cohort. Conclusion: This study revealed a high prevalence of NH and ND, with MH emerging as the next most common phenotype in a low-risk, urban Singaporean population. These findings support the potential role of ABPM to unmask hypertension phenotypes. Longitudinal follow up of this cohort could determine their prognostic significance and implications for cardiovascular risk stratification.
1 January 2025 in Proceedings of Singapore Healthcare
This study aimed to assess the literacy of Human Papillomavirus (HPV) and its vaccine between genders in young adults in an Asian urban community. The secondary aim was to identify factors associated with the acceptability of HPV vaccine among unvaccinated males. A self-administered e-survey was distributed via convenience sampling over 3 months in 2022 in Singapore. Demographic data and literacy on HPV and HPV vaccine were collected from young adults aged 15–24 years through a secured electronic platform. Chi-square or Fisher’s exact test was used to examine the association between acceptability of vaccine uptake and literacy of HPV and HPV vaccine. 591 youths comprising of 236 (40%) males and 355 (60%) females completed the survey. HPV vaccination uptake rate was low in males (11.4%) but high in females (80%). Both genders had low awareness on the ability of HPV to infect males (50%) and majority (80%) were unaware of the benefits of HPV vaccine to males. Among unvaccinated males, 82.5% accepted the recommendation of providing males with HPV vaccination, and 72.7% were acceptable towards taking up the vaccine. The main barriers to vaccination were cost (78.9%) and inconvenience (52.2%), while lifelong immunity (67.5%) and government health policies (67%) were identified as enablers. Young adults had low literacy on HPV’s ability to infect males and the benefits of HPV vaccine to both genders. Its uptake in males would depend on their acceptance of the HPV vaccine, cost, administration convenience and duration of its immunity post-vaccination.